In The News Posted January 9, 2020 Share Posted January 9, 2020 TOKYO, Jan. 9, 2020 /PRNewswire/ -- Healios K.K. ("the Company"); (TSE: 4593), Japan's leading clinical stage biotechnology company harnessing the potential of stem cells for regenerative therapies announces that its Chairman and Chief Executive Officer, Hardy TS Kagimoto, MD, will... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.